# A Study of TYK-00540 in Adult Patients With Solid Tumors

> **NCT06246071** · PHASE1 · RECRUITING · sponsor: **TYK Medicines, Inc** · enrollment: 156 (estimated)

## Conditions studied

- Locally Advanced or Metastatic Solid Tumors

## Interventions

- **DRUG:** TYK-00540

## Key facts

- **NCT ID:** NCT06246071
- **Lead sponsor:** TYK Medicines, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-02
- **Primary completion:** 2026-12-05
- **Final completion:** 2026-12-05
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06246071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06246071, "A Study of TYK-00540 in Adult Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06246071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*